Cingulate Sees Positive Results in Trial for ADHD Treatment

By Chris Wack Cingulate said it saw positive results from a Phase 3 adult efficacy and safety study of its lead candidate, CTx-1301, for the treatment of...

Related Keywords

Chris Wack , Drug Administration , Permanent Product Measure , Global Impression Scale , Article Normal , Neurodevelopmental Disorders , Political General News , Health , Medical Conditions , Mental Disorders , Synd , Icing , Us17248w1053 , Political , General News ,